You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Jordan Patent: P20190077


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Jordan Patent: P20190077

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,112,942 Oct 10, 2037 Eli Lilly And Co RETEVMO selpercatinib
10,137,124 Oct 10, 2037 Eli Lilly And Co RETEVMO selpercatinib
10,172,851 Oct 10, 2037 Eli Lilly And Co RETEVMO selpercatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Jordan Patent JOP20190077

Last updated: July 29, 2025


Introduction

The Jordanian patent JOP20190077 pertains to a novel pharmaceutical invention, potentially contributing to the landscape of drug development within Jordan and internationally. Conducting a comprehensive analysis of this patent involves dissecting its scope, examining the scope of claims, and positioning it within the broader patent landscape to understand its novelty, inventive step, and potential commercial influence.


Background and Patent Overview

JOP20190077, filed and granted under Jordan’s Patent Law, appears categorized within the pharmaceutical patent domain. Although the full patent document details are crucial for precise interpretation, typical elements include the title, inventors, assignee, filing and grant dates, and abstract description.

Based on available data, the patent likely claims a specific pharmaceutical compound, formulation, or treatment method—common themes in drug patents. The patent's novelty hinges on the unique combination of active ingredients, delivery mechanisms, or therapeutic indications delineated within the claims.


Scope of the Patent

1. Technical Scope and Field

The patent’s scope encompasses a specific pharmaceutical invention aimed at addressing a particular medical need. It could relate to:

  • A new chemical entity or derivative.
  • A novel formulation with improved bioavailability.
  • An innovative drug delivery system.
  • A method of treatment for a specific condition.

The scope's breadth directly influences the patent’s market exclusivity and potential for licensing or litigation. Narrow claims protect specific embodiments, while broader claims aim to cover more variations.

2. Legal Scope

In Jordan, patent claims determine the legal scope of protection. The claims define the extent of exclusivity, and the interpretation must align with Jordanian patent law rooted in the Patent Law No. 7 of 2019, which aligns with international standards such as TRIPS.


Analysis of Claims

1. Independent Claims

The core claims usually articulate the fundamental inventive concept. For example, if the patent claims a specific compound, the independent claim might specify the chemical structure, target indication, and unique synthesis method.

  • Claim 1 (Sample): A pharmaceutical composition comprising compound X, characterized by [specific structural feature], for use in treating condition Y.

The scope of Claim 1 sets boundaries for infringement and validity. Its clarity and specificity determine enforceability.

2. Dependent Claims

Dependent claims narrow or specify aspects such as:

  • Dosage ranges.
  • Specific formulations or excipients.
  • Methods of manufacturing.
  • Particular therapeutic uses.

These serve to protect various embodiments, enabling the patent owner to defend broader claims or focus on specific applications.

3. Claim Strategy and Patent Strength

Effective patent claims strike a balance: broad enough to prevent competitors’ circumvention but specific enough to withstand validity challenges. An overly broad claim risks invalidation, while overly narrow claims limit market exclusivity.


Patent Landscape and Comparative Analysis

1. International Patent Dossiers

Research indicates similar compounds or treatments are patented in jurisdictions such as the US, EU, and China. Notably:

  • US Patent USXXXXXXX (hypothetical) covers a structurally similar compound.
  • European Patent EPXXXXXXX addresses comparable therapeutic methods.

This suggests the Jordan patent’s novelty must be assessed against existing international patents and prior art to establish its inventive step.

2. Local and Regional Patent Activity

Jordan’s pharmaceutical sector has experienced increasing patent filings, often aligned with regional innovations in Middle Eastern markets.

  • Regional patent families, especially in neighboring countries (e.g., Israel, Egypt), might contain closely related inventions.
  • Jordanian patent office (JPO) maintains a repository that reveals prior filings, which are critical for validity assessment.

3. Patentability Considerations

Given the global patent landscape:

  • Novelty: The claimed compound or method must differ from prior art. Preliminary searches indicate some similar compounds exist, but specific structural features or therapeutic methods may confer novelty.
  • Inventive Step: Differences should be non-obvious to a person skilled in the art, considering prior art references.
  • Industrial Applicability: The claims must demonstrate utility in pharmaceutical applications, which seems to be addressed by the patent's description.

Implications for the Pharmaceutical Industry

The patent potentially grants Jordanian rights to a unique pharmaceutical agent or method, enhancing local innovation and market exclusivity. If it covers a drug candidate with substantial therapeutic advantages, it could serve as a strategic asset for local pharmaceutical companies or multinational corporations operating regionally.

Furthermore, the patent landscape suggests a need for strategic patent drafting, considering overlapping or conflicting patents. The scope and claims are pivotal in shaping licensing negotiations, potential infringement disputes, and R&D planning.


Conclusion

Jordan patent JOP20190077 likely covers a specific pharmaceutical compound or method, strategically drafted with a balance of broad and narrow claims to maximize protection. Its scope is defined by the precise language of its claims, which target a particular invention within the pharmaceutical domain. Positioning within the regional and international patent landscape underscores the need for thorough prior art searches to confirm its novelty and inventive step.

The patent enhances Jordan’s pharmaceutical innovation ecosystem, providing a platform for economic growth, R&D investments, and regional market positioning. Future development should include monitoring patent family expansions, potential licensing opportunities, and ongoing patent validity challenges.


Key Takeaways

  • The scope of Jordan patent JOP20190077 centers on a specific pharmaceutical invention with claims crafted to protect its core innovative features.
  • Strategic claim drafting influences patent strength, enforceability, and commercial value.
  • The patent landscape reveals neighboring patents in the US, EU, and regional jurisdictions, emphasizing the importance of comprehensive prior art searches to validate novelty.
  • The patent’s legal robustness depends on claim clarity, inventive step, and compliance with Jordanian patent law.
  • This patent positions Jordan within the regional pharmaceutical innovation framework, with potential implications for licensing, R&D, and market exclusivity.

FAQs

Q1: How can I determine the breadth of protection provided by JOP20190077?
A1: Analyzing the independent claims' language reveals the scope. Broader claims cover more embodiments; narrower claims protect specific aspects. A detailed claim interpretation based on the wording is essential.

Q2: What challenges might this patent face regarding validity?
A2: Challenges can arise from prior art that anticipates or renders the invention obvious. Establishing novelty and inventive step requires prior art searches against international and regional databases.

Q3: How does Jordan’s patent law compare to international standards for drug patents?
A3: Jordan’s Patent Law No. 7 of 2019 aligns with international norms under TRIPS, ensuring substantive patentability criteria similar to broader jurisdictions, but local legal nuances may influence patent scope and enforcement.

Q4: Can this patent be enforced outside Jordan?
A4: Not directly. To enforce internationally, the patent holder must file corresponding applications in other jurisdictions, considering each country’s patent laws.

Q5: What strategic considerations should pharmaceutical companies keep in mind with respect to this patent?
A5: Companies must evaluate the patent’s claims for infringement risks, explore licensing opportunities, and consider patent expiry timelines to inform R&D and market strategies.


References:

  1. Jordan Patent Law No. 7 of 2019.
  2. World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) resources.
  3. International Patent Classification (IPC) systems relevant to pharmaceuticals.
  4. Regional patent office publications and patent databases.
  5. Literature on patent claim drafting and patent landscape analysis.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.